首页> European radiology> MR outperformed CT in evaluating RECIST response to neoadjuvant therapy in locally advanced esophageal squamous cell carcinoma.

MR outperformed CT in evaluating RECIST response to neoadjuvant therapy in locally advanced esophageal squamous cell carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Wenshi,Li

第一单位： Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.;HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Henan Cancer Hospital, Zhengzhou, China.

作者： Wenshi,Li ^[1] ; Zhaoqi,Wang ^[1] ; Zihan,Wang ^[1] ; Yafeng,Dong ^[1] ; Funing,Chu ^[1] ; Yue,Huang ^[1] ; Mengzhu,Wang ^[2] ; Omar,Darwish ^[3] ; Dominik,Nickel ^[3] ; Keke,Zhao ^[1] ; Yan,Zheng ^[4] ; Ihab R,Kamel ^[5] ; Jinrong,Qu ^[6]

作者单位： Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.;HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Henan Cancer Hospital, Zhengzhou, China. ^[1] MR Research Collaboration Team, Siemens Healthineers Ltd., Beijing, China. ^[2] Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany. ^[3] Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. ^[4] Department of Radiology, Anschutz Medical Campus, University of Colorado Denver, Aurora, CO, USA. ^[5] Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. qjryq@126.com.;HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Henan Cancer Hospital, Zhengzhou, China. qjryq@126.com. ^[6]

关键词 Esophageal squamous cell carcinoma Magnetic resonance imaging Response evaluation criteria in solid tumors Tomography (x-ray computed)Treatment outcome

DOI 10.1007/s00330-025-12139-2

PMID 41251725

发布时间 2025-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交